RELATED STORIES

Biotech IPOs: More to be Expected?


October 17, 2012 | Are Biotech IPOs back? Two recent offerings netted 20% above their offer price, following a year of strong performances by the biotech sector. Forbes
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1
RELATED
RESOURCES & PRODUCTS
Cloud Computing Usage in Biotech & Pharma Market Study
Cloud Computing Usage in Biotech & Pharma Market Study
What Do Regulatory Agencies Really Expect for Comparability? DVD
What Do Regulatory Agencies Really Expect for Comparability? DVD
PAREXEL's Pharmaceutical R&D Statistical Sourcebook 2005/2006

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.